Professor of virology at Sorbonne Université, Clinical virologist at Pitié-Salpêtrière Hospital
BIOGRAPHY
JUN 29, 2022 8:00 AM PDT
Two years into the COVID-19 pandemic... What can serology testing tell us about immune status?
Speakers
-
Jean-François Mouscadet
Associate Vice President of Research & Development, Bio-Rad Laboratories, Clinical DiagnosticsBIOGRAPHY -
Heidi Scholz
Research & Development Manager, Bio-Rad Laboratories - Clinical ImmunologyBIOGRAPHY
Event Date & Time
Date: June 29, 2022
Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST)
Abstract
As of May 2022, there have been more than 500 million confirmed cases of COVID-19. Additionally, more than 5 billion people have received at least one dose of a COVID-19 vaccine. Immune responses to natural COVID-19 infections, including to the numerous variants and subvariants, and to the variety of available vaccines are unique.
Two years into the global COVID-19 pandemic, the role of serology testing to evaluate immune responses has not yet been defined. This webinar will explore the role of serology testing to assess immune status.
Bio-Rad SARS-CoV-2 products provide you and your laboratory with efficient new ways to quantitatively characterize immune responses.
Learning Objectives
- Understand how SARS-CoV-2 serology testing results correlate with individual immune responses to COVID-19 infections or vaccinations
- Understand the value of SARS-CoV-2 serology testing and potential role of quantitative assays in determining protection against COVID-19
- Review serological responses from SARS-CoV-2 variants with a new quantitative assay that can differentiate multiple neutralizing and binding antibodies within a single test
Webinars will be available for unlimited on-demand viewing after live event.